eComment. Rise of Ticagrelor and the vital necessity for specific reversal agents

Interact Cardiovasc Thorac Surg. 2016 Feb;22(2):410. doi: 10.1093/icvts/ivv351.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists*
  • Treatment Outcome*

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists